BCG treatment of malignant pleural effusions in the rat
Open Access
- 1 October 1976
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 34 (4) , 368-373
- https://doi.org/10.1038/bjc.1976.179
Abstract
Intrapleurally injected cells of an ascitic rat tumour produced intrapleural effusions and solid pleural deposits. BCG, or its methanol extraction residue (MER) injected into the pleural space, suppressed tumour development and prolonged survival. Treatment was effective if given a few days before or after tumour injection. In contrast, active specific immunotherapy by repeated s.c. injection of viable or radiation-attenuated tumour cells in admixture with BCG was unsuccessful, and did not improve the response to intrapleural BCG treatment.Keywords
This publication has 17 references indexed in Scilit:
- REGIONAL IMMUNOTHERAPY OF LUNG CANCER WITH INTRAPLEURAL B.C.G.The Lancet, 1976
- A 5-YEAR CONTROLLED STUDY OF B.C.G. AND RADIOTHERAPY FOR INOPERABLE LUNG CANCERThe Lancet, 1976
- Therapeutic effect of intratumoral injection of BCG and other substances in rats and miceInternational Journal of Cancer, 1975
- Quantitative studies on cell‐mediated immunity in the pleural cavity of guinea‐pigsThe Journal of Pathology, 1975
- BCG immunotherapy of rat tumours in athymic nude miceNature, 1975
- Bcg therapy of pleural and peritoneal growth of transplanted rat tumoursInternational Journal of Cancer, 1975
- Bacillus Calmette-Guerin in the treatment of neoplastic disease.1974
- Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lungThorax, 1974
- BCG and CancerNew England Journal of Medicine, 1974
- BCG Immunotherapy of a Rat SarcomaBritish Journal of Cancer, 1973